Stem Cell Agency Funds Phase 3 Clinical Trial For Lou Gehrig’s Disease

Lou Gehrigs Disease

A neurodegenerative disease when occurred leads us to a series of complications all together. The occurrence of this devastating disease exposes us to dysarthria – a condition in which we cannot speak properly, dyspnea- a distress in breathing, and also dysphagia, which deteriorates our ability to swallow easily. It is rapidly characterized by an intense […]

Continue reading